Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

27 Results

Guidelines and Advice

Alemtuzumab for the Treatment of T-cell Prolymphocytic Leukemia

Status: Archived
ID: 6-22

Jan 2007

Guidelines and Advice

The Role of Liposomal Doxorubicin in the Treatment of Metastatic Breast Cancer

Status: Archived
ID: CED 4

May 2007

Guidelines and Advice

The Role of Albumin-bound Paclitaxel (Abraxane) in the Treatment of Metastatic Breast Cancer

Status: Archived
ID: CED 6

Jun 2007

Guidelines and Advice

Cancer Care Ontario Bladder Cancer Guideline: An Endorsement of the 2017 American Urological Association Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA, ASCO, ASTRO, SUO Guide

Status: In-Review
ID: GL-END 3-21

Jan 2018

Drug

dexamethasone

Quick Link(s):

Patient Info Sheet

Jan 2018

Drug

prednisone

Quick Link(s):

Patient Info Sheet

Jan 2018

Guidelines and Advice

Iodine-131 Tositumomab in Lymphoma

Status: Archived
ID: 6-19

Jan 2007

Guidelines and Advice

Postoperative Adjuvant Chemotherapy in Completely Resected Non-Small Cell Lung Cancer: Guidance for Nurses

Status: Archived
ID: 7-1-2N

Dec 2007

Statistical Reports

Ontario Cancer Statistics 2018

Jan 2018

Cancer facts

Many cancers caused by infections in Ontario are preventable

Jan 2018

Guidelines and Advice

Patient Indications for Mohs Micrographic Surgery

Status: Current
ID: GL 8-11

Jan 2018

Guidelines and Advice

Recombinant Humanized Thyroid Stimulating Hormone (rhTSH) Preparation Prior To Radioiodine Ablation in Patients Who Have Undergone Thyroidectomy for Papillary or Follicular Thyroid Cancer

Status: Archived
ID: CED 5

May 2007

Pages